Cargando…
Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open‐label, blinded endpoint clinical trial, enrolling patients with interna...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282815/ https://www.ncbi.nlm.nih.gov/pubmed/30295338 http://dx.doi.org/10.1002/ana.25352 |
_version_ | 1783379071613272064 |
---|---|
author | Tian, De‐Cai Shi, Kaibin Zhu, Zilong Yao, Jia Yang, Xiaoxia Su, Lei Zhang, Sheng Zhang, Meixia Gonzales, Rayna J. Liu, Qiang Huang, DeRen Waters, Michael F. Sheth, Kevin N. Ducruet, Andrew F. Fu, Ying Lou, Min Shi, Fu‐Dong |
author_facet | Tian, De‐Cai Shi, Kaibin Zhu, Zilong Yao, Jia Yang, Xiaoxia Su, Lei Zhang, Sheng Zhang, Meixia Gonzales, Rayna J. Liu, Qiang Huang, DeRen Waters, Michael F. Sheth, Kevin N. Ducruet, Andrew F. Fu, Ying Lou, Min Shi, Fu‐Dong |
author_sort | Tian, De‐Cai |
collection | PubMed |
description | OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open‐label, blinded endpoint clinical trial, enrolling patients with internal carotid artery or middle cerebral artery proximal occlusion within 4.5 to 6 hours from symptom onset. Patients were randomly assigned to receive alteplase alone or alteplase with fingolimod. All patients underwent pretreatment and 24‐hour noncontrast computed tomography (CT)/perfusion CT/CT angiography. The coprimary endpoints were the decrease of National Institutes of Health Stroke Scale scores over 24 hours and the favorable shift of modified Rankin Scale score (mRS) distribution at day 90. Exploratory outcomes included vessel recanalization, anterograde reperfusion, and retrograde reperfusion of collateral flow. RESULTS: Each treatment group included 23 patients. Compared with alteplase alone, patients receiving fingolimod plus alteplase exhibited better early clinical improvement at 24 hours and a favorable shift of mRS distribution at day 90. In addition, patients who received fingolimod and alteplase exhibited a greater reduction in the perfusion lesion accompanied by suppressed infarct growth by 24 hours. Fingolimod in conjunction with alteplase significantly improved anterograde reperfusion of downstream territory and prevented the failure of retrograde reperfusion from collateral circulation. INTERPRETATION: Fingolimod may enhance the efficacy of alteplase administration in the 4.5‐ to 6‐hour time window in patients with a proximal cerebral arterial occlusion and salvageable penumbral tissue by promoting both anterograde reperfusion and retrograde collateral flow. These findings are instructive for the design of future trials of recanalization therapies in extended time windows. Ann Neurol 2018;84:725–736 |
format | Online Article Text |
id | pubmed-6282815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62828152018-12-11 Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow Tian, De‐Cai Shi, Kaibin Zhu, Zilong Yao, Jia Yang, Xiaoxia Su, Lei Zhang, Sheng Zhang, Meixia Gonzales, Rayna J. Liu, Qiang Huang, DeRen Waters, Michael F. Sheth, Kevin N. Ducruet, Andrew F. Fu, Ying Lou, Min Shi, Fu‐Dong Ann Neurol Research Articles OBJECTIVE: The present study was undertaken to determine the efficacy of coadministration of fingolimod with alteplase in acute ischemic stroke patients in a delayed time window. METHODS: This was a prospective, randomized, open‐label, blinded endpoint clinical trial, enrolling patients with internal carotid artery or middle cerebral artery proximal occlusion within 4.5 to 6 hours from symptom onset. Patients were randomly assigned to receive alteplase alone or alteplase with fingolimod. All patients underwent pretreatment and 24‐hour noncontrast computed tomography (CT)/perfusion CT/CT angiography. The coprimary endpoints were the decrease of National Institutes of Health Stroke Scale scores over 24 hours and the favorable shift of modified Rankin Scale score (mRS) distribution at day 90. Exploratory outcomes included vessel recanalization, anterograde reperfusion, and retrograde reperfusion of collateral flow. RESULTS: Each treatment group included 23 patients. Compared with alteplase alone, patients receiving fingolimod plus alteplase exhibited better early clinical improvement at 24 hours and a favorable shift of mRS distribution at day 90. In addition, patients who received fingolimod and alteplase exhibited a greater reduction in the perfusion lesion accompanied by suppressed infarct growth by 24 hours. Fingolimod in conjunction with alteplase significantly improved anterograde reperfusion of downstream territory and prevented the failure of retrograde reperfusion from collateral circulation. INTERPRETATION: Fingolimod may enhance the efficacy of alteplase administration in the 4.5‐ to 6‐hour time window in patients with a proximal cerebral arterial occlusion and salvageable penumbral tissue by promoting both anterograde reperfusion and retrograde collateral flow. These findings are instructive for the design of future trials of recanalization therapies in extended time windows. Ann Neurol 2018;84:725–736 John Wiley and Sons Inc. 2018-11-02 2018-11 /pmc/articles/PMC6282815/ /pubmed/30295338 http://dx.doi.org/10.1002/ana.25352 Text en © 2018 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Tian, De‐Cai Shi, Kaibin Zhu, Zilong Yao, Jia Yang, Xiaoxia Su, Lei Zhang, Sheng Zhang, Meixia Gonzales, Rayna J. Liu, Qiang Huang, DeRen Waters, Michael F. Sheth, Kevin N. Ducruet, Andrew F. Fu, Ying Lou, Min Shi, Fu‐Dong Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
title | Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
title_full | Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
title_fullStr | Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
title_full_unstemmed | Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
title_short | Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
title_sort | fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282815/ https://www.ncbi.nlm.nih.gov/pubmed/30295338 http://dx.doi.org/10.1002/ana.25352 |
work_keys_str_mv | AT tiandecai fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT shikaibin fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT zhuzilong fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT yaojia fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT yangxiaoxia fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT sulei fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT zhangsheng fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT zhangmeixia fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT gonzalesraynaj fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT liuqiang fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT huangderen fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT watersmichaelf fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT shethkevinn fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT ducruetandrewf fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT fuying fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT loumin fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow AT shifudong fingolimodenhancestheefficacyofdelayedalteplaseadministrationinacuteischemicstrokebypromotinganterogradereperfusionandretrogradecollateralflow |